GLOBAL CORONARY STENT MARKET SIZE TO CROSS USD 11 BILLION BY 2024, GROWING AT A CAGR OF 7% DURING THE FORECAST PERIOD

Coronary Stent Market Size, Share, & Trends Analysis Report by Product (Drug-Eluting, Bare Metal, and Bioresorbable Stents), Design (Permanent and Fully Degradable), End-Users (Hospitals, Specialty Cardiology Centers, and Ambulatory Surgical Centers), and Geography (North America, Europe, APAC, Latin America, and Middle East & Africa), Industry Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Share & Forecast, 2019-2024

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

266 Pages

icon-table

32 Tables

icon-chart

109 Charts

icon-region

5 Regions

icon-country

12 Countries

icon-company

41 Companies

icon-market

4 Market Segment

CORONARY STENT MARKET REPORT SCOPE

Report Attribute Details
Market Size (REVENUE) USD 11 BILLION (2024)
CAGR 7% (2019-2024)
Base Year 2018
Forecast Year 2019-2024
Market Segments Product (Drug-Eluting, Bare Metal, and Bioresorbable Stents), Design (Permanent and Fully Degradable), End-Users (Hospitals, Specialty Cardiology Centers, and Ambulatory Surgical Centers)
Geographic Analysis North America, Europe, APAC, Latin America, and Middle East & Africa
Countries Covered Brazil, Canada, China, France, Germany, India, Japan, Mexico, Saudi Arabia, Turkey, UK, and US

INDUSTRY INSIGHTS

The coronary stent market size to cross USD 11 billion by 2024, and growing at a CAGR of 7% during the forecast period. The increasing prevalence of cardiovascular diseases (CVD), especially vascular diseases, has been a major growth driver for the global market. Over the years, coronary stent has witnessed several technological enhancements, particularly design innovations. Manufacturers are focusing primarily on R&D activities and commercialization of innovative drug-eluting stent (DES) systems due to the high prevalence of coronary artery diseases.   

Several government agencies and vendors are spreading awareness and information about the availability of the latest-generation heart stent and its advantage over conventional invasive procedure. The emergence of bioresorbable vascular scaffolds, the high growth potential of third generation DESs with low strut thickness, and new product approvals and launches are some of the primary factors accelerating the global coronary stent market growth.  Many surgeons are implanting DESs with low strut thickness for treating CAD. This is expected to increase the commercialization of a diverse range of DESs with low strut thickness, thereby positively contributing to the growth of the market globally.

Further, new product approvals are contributing majorly toward the growth of the industry and are likely to have a significant impact on the industry in the coming years. Abbott, B. Braun Melsungen, Boston Scientific, Biosensors International Group, Medtronic, BIOTRONIK, Microport Scientific, and Terumo have launched a diverse range of drug-eluting stent in recent years, which is expected to augur well for the growth of the global market. 

CORONARY STENT MARKET SEGMENTATION

The research report includes a detailed segmentation by

  • Product
  • Design
  • End-users
  • Geography

INSIGHTS BY PRODUCT

The high prevalence/incidence of CVDs is a major driver for the growth of drug-eluting stents. The high incidence of coronary artery disease(CAD), coupled with the increasing elderly population and complications such as heart attacks, is a significant factor driving the demand for drug-eluting stents.

Bare metal stent industry is growing at a steady rate. High CAD occurrences, technological advancements, and a steady increase in demand in emerging economies are factors responsible for growth of bare metal stent. Further, the demand for bare-metal stent is likely to grow primarily from price-sensitive industry such as developing and low-income countries, where the uptake of PCI procedures has steadily increased over the past few years.

Bioresorbable stent segment is growing at a faster pace and is likely to witness rapid growth during the forecast period. With the availability of a few commercial and promising investigational devices, bioresorbable product is likely to offer tremendous growth opportunities for vendors in coming years.

INSIGHTS BY DESIGN

The permanent coronary stent segment is growing significantly and captured more than half of the market in 2018. Permanent heart stent is a non-degradable device made up from metal alloys such as stainless steel, cobalt chromium, and platinum chromium. They are gaining prominence due to their safety and efficacy.

Fully degradable heart stent industry is growing at a stable rate. The rise in CVDs, especially vascular & heart diseases, has become a major growth driver for innovative fully degradable types. Further, the manufacturers are focusing on R&D activities and commercialization of innovative products such as BRSs. Several emerging and major players are actively engaged in the research and development and commercialization of BRSs due to their huge potential. For instance, Abbott is developing Absorb, second-generation BRS, and is actively conducting clinical trials to gain regulatory approvals.

INSIGHTS BY END-USER

Hospitals are the largest end-users segment in the global industry. The growing aging population, changing lifestyle patterns, and the increasing prevalence of CVDs are fueling growth. Further, a significant number of patients prefer to undergo surgeries in hospitals due to better reimbursement policies. The availability of reimbursement in hospitals is a major driver for the high volume of PCI procedures in the healthcare sector. The demand for highly advanced and innovative PCI procedures like robot-assisted techniques are being performed to implant a diverse array of drug eluting, bare metal, and bioabsorbable type.

Specialty cardiology centers and interventional cardiology training are growing at a steady rate due to the presence of sophisticated infrastructure related to the diagnosis and treatment of CVDs. Significant advances in surgical procedures and the high demand for CVD care have also contributed to the growth of the segment. ASCs are outpatient surgery centers that provide advanced healthcare facilities to patients. These centers are cost-effective and offer quality care with the minimal indirect cost of treatment. Cohesively, these factors are expected to drive the global industry during the forecast period.

INSIGHTS BY GEOGRAPHY

North America captured half of the global coronary stent market share in 2018. The presence of a large pool of patient population with CAD requiring, a high acceptance of advanced and innovative product, and high awareness toward stent-based PCI procedures have collectively supported North America’s dominance in the global industry.

Germany, the UK, France, Italy, and Spain are the major revenue contributors in the global coronary stent market in Europe. The presence of highly sophisticated healthcare infrastructure, high awareness regarding advantages of PCI procedures, and increased R&D investments on innovative coronary stents are major driver driving the Europe market.

APAC is likely to offer lucrative opportunities for a diverse range of coronary stents. Favorable government initiatives and the growing medical tourism industry in APAC are expected to drive the market in the region during the forecast period.

Latin America and MEA accounted small shares in 2018. Brazil and Mexico are the major revenue contributors in the Latin America region, whereas, Turkey, Saudi Arabia, South Africa, Israel, and a few Gulf countries are major revenue contributors in the MEA region.

INSIGHTS BY VENDORS

The coronary stent market is highly dynamic due to the presence of several global, regional, and local players offering a broad range of products. Vendors, especially global players, are increasingly focusing on pursuing inorganic growth strategies such as acquisitions and investments in startup and emerging companies to expand their presence, enhance product portfolio, and improve expertise in the global industry. Leading players are focusing on implementing strategies such as product approvals, expanded indication approvals, conducting clinical trials, marketing, and promotional activities, acquisitions, increase R&D investment, and strengthen their distribution networks to enhance their industry share and presence in the market. 

The global coronary stent market research report includes in-depth coverage of the industry analysis, competitive landscape with revenue and forecast insights for the following segments:

Market Segmentation by Product

  • Drug-eluting
  • Bare metal
  • Bioresorbable

By Design

  • Permanent
  • Fully degradable

By End-users

  • Hospitals
  • Specialty cardiology centers
  • Ambulatory surgical centers

By Geography

  • North America
    • United States
    • Canada
  • Europe
    • UK
    • Germany
    • France
  • APAC
    • China
    • India
    • Japan
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • Turkey
    • Saudi Arabia

Frequently Asked Questions

What is the coronary stent market size and growth rate during the forecast period?

Coronary stent market size will cross USD 11 billion by 2024, growing at a CAGR of 7%.

What are the factors influencing the global coronary stent market growth?

The growing prevalence of cardiovascular diseases (CVD), especially vascular diseases, has been a major growth driver for the global coronary stent market.

What are top trends, drivers, restraints, and opportunities in the global industry?

The emergence of bioresorbable vascular scaffolds, the high growth potential of third generation DESs with low strut thickness, technological advancements and innovations, and new product approvals and launches are major factors, which are expected to drive the market in coming years.

Who are the key player and what are their market shares?

Abbott, Boston Scientific, Medtronic, BIOTRONIK, Terumo, Braun Melsungen, Biosensors International Group are the leading market players having signification coronary stent market share.

Who are the major revenue contributors in the Europe region?

Germany, the UK, France, Italy, and Spain are the major revenue contributors in the global coronary stent market in Europe.

Download Free Sample

The global coronary stent market is likely to reach more than $11 billion by 2024, growing at a CAGR of around 7% during 2018–2024.

The market is undergoing several transformations. The emergence of bioresorbable vascular scaffolds, the high growth potential of third generation DESs with low strut thickness, technological advancements and innovations, and new product approvals and launches are major factors, which are expected to drive the market in coming years.

Base Year:          2018

Forecast Year:    2019–2024

The study considers the present scenario of the market and its market dynamics for the period 2019−2024. The report covers a detailed overview of several market growth enablers, restraints, and trends. It covers both the demand and supply aspect of the market. It profiles and examines leading and prominent companies operating in the market.

Prominent Vendors

  • Abbott
    • Business Overview
    • Major PRODUCT Offerings
    • Key Strategies
    • Key Strengths
    • Key Opportunities
  • Boston Scientific
  • Medtronic
  • BIOTRONIK
  • Terumo
  • Braun Melsungen
  • Biosensors International Group

Other Prominent Vendors

  • Arterial Remodeling Technologies
    • Business Overview
    • Major Product Offering
  • Alvimedica
  • Balton
  • Cardionovum
  • CeloNovaBioSciences
  • Comed
  • Cordis
  • Elixir Medical
  • Endocor
  • Eucatech
  • Eurocor Tech
  • Hexacath
  • InSitu Technologies
  • Innovative Healthcare Technologies
  • Lepu Medical Technology (Beijing)
  • Medinol
  • Meril Life Sciences
  • Micell Technologies
  • MicroPort Scientific
  • Minvasys
  • OrbuSneich Medical
  • Q3 Medical Devices
  • REVA Medical
  • Rontis
  • S3V Vascular Technologies
  • Sahajanand Medical Technologies
  • SCITECH
  • Stentys
  • Svelte Medical
  • Translumina Therapeutics
  • USM Healthcare
  • Vascular Concepts
  • Wellinq

Market Segmentation by Product

  • Drug-eluting stents
  • Bare metal stents
  • Bioresorbable stents

Market Segmentation by Design

  • Permanent coronary stents
  • Fully degradable coronary stents

Market Segmentation by End-users

  • Hospitals
  • Specialty cardiology centers
  • Ambulatory surgical centers

Market Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
  • APAC
    • China
    • India
    • Japan
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • Turkey
    • Saudi Arabia

 

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage

4.1 Market Definition

4.1.1 Inclusions

4.1.2 Exclusions

4.2 Base Year

4.3 Scope of the study

4.4 Market Segments

4.4.1 Coronary Stent Market Segmentation by Products

4.4.2 Coronary Stent Market Segmentation by Design

4.4.3 Coronary Stent Market Segmentation by End-users

4.4.4 Coronary Stent Market Segmentation by Geography

5 Report Assumptions & Caveats

5.1 Key Caveats

5.2 Currency Conversion

5.3 Market Derivation

6 Market at a Glance

7 Introduction

7.1 Coronary Artery Disease (CAD): An Overview

7.1.1 Symptoms

7.1.3 Etiology

7.1.4 Complications

7.1.5 Diagnosis

7.1.6 Treatment

7.2 PCI: An Overview

7.2.1 Coronary Stents

8 Market Dynamics

8.1 Market Growth Enablers

8.1.1 Increased Prevalence/Incidence of Coronary Artery Disease

8.1.2 High Demand for DESs with Low Strut Thickness

8.1.3 High Demand for Coronary Stents in Emerging Markets

8.1.4 Technological Advancements/Innovations in Stent Platforms

8.2 Market Growth Restraints

8.2.1 Stringent Regulations for Product Approvals

8.2.2 Availability of Alternative Treatment Methods for CAD

8.2.3 Complications Associated with Coronary Stenting Procedure

8.3 Coronary Stent Market Opportunities & Trends

8.3.1 Emergence of Bioresorbable Vascular Scaffolds

8.3.2 High Growth Potential of Third-generation DESs

8.3.3 New Product Approvals/Launches

9 Global Coronary Stent Market

9.1 Coronary Stent Market Overview

9.2 Market Size & Forecast

9.3 Five Forces Analysis

9.3.1 Threat of New Entrants

9.3.2 Bargaining Power of Suppliers

9.3.3 Bargaining Power of Buyers

9.3.4 Threat of Substitutes

9.3.5 Competitive Rivalry

10 By Product Type

10.1 Market Snapshot & Growth Engine

10.2 Coronary Stent Market Overview by Product type

10.3 Drug-eluting Stents

10.3.1 Market Overview

10.3.2 Market Size & Forecast

10.3.3 Global Drug-eluting Stents Market by Product Type

10.3.4 Second-generation Drug-eluting Stents: Market Size & Forecast

10.3.5 Latest-generation Drug-eluting Stents: Market Size & Forecast

10.4 Bare Metal Stents

10.4.1 Market Overview

10.4.2 Market Size & Forecast

10.5 Bioresorbable Stents

10.5.1 Market Overview

10.5.2 Market Size & Forecast

11 By Design Type

11.1 Market Snapshot & Growth Engine

11.2 Coronary Stent Market Overview by Design type

11.3 Permanent Coronary Stents

11.3.1 Market Size & Forecast

11.4 Fully Degradable Coronary Stents

11.4.1 Market Size & Forecast

12 By End-Users

12.1 Market Snapshot & Growth Engine

12.2 Coronary Stent Market Overview by End-users

12.3 Hospitals

12.3.1 Market Size & Forecast

12.4 Specialty Cardiology Centers

12.4.1 Market Size & Forecast

12.5 ASCs

12.5.1 Market Size & Forecast

13 By Geography

13.1 Market Snapshot & Growth Engine

13.2 Coronary Stent Market Overview by Geography

14 North America

14.1 Market Overview

14.2 Market Size & Forecast

14.3 Key Countries

14.3.1 US: Coronary Stent Market Size & Forecast

14.3.2 Canada:Coronary Stent Market Size & Forecast

15 Europe

15.1 Market Overview

15.1.1 Market Size & Forecast

15.2 Key Countries

15.2.1 Germany:Coronary Stent Market Size & Forecast

15.2.2 France:Coronary Stent Market Size & Forecast

15.2.3 UK:Coronary Stent Market Size & Forecast

16 APAC

16.1 Market Overview

16.2 Market Size & Forecast

16.3 Key Countries

16.3.1 Japan:Coronary Stent Market Size & Forecast

16.3.2 China: Coronary Stent Market Size & Forecast

16.3.3 India:Coronary Stent Market Size & Forecast

17 Latin America

17.1 Market Overview

17.2 Market Size & Forecast

17.3 Key Countries

17.3.1 Brazil:Coronary Stent Market Size & Forecast

17.3.2 Mexico:Coronary Stent Market Size & Forecast

18 Middle-East and Africa

18.1 Market Overview

18.2 Market Size & Forecast

18.3 Key Countries

18.3.1 Turkey:Coronary Stent Market Size & Forecast

18.3.2 Saudi Arabia:Coronary Stent Market Size & Forecast

19 Competitive Landscape

19.1 Competition Overview

19.2 Market Share Analysis

20 Key Company Profiles

20.1 Abbott

20.1.1 Business Overview

20.1.2 Abbott in Global Coronary Stents Market

20.1.3 Major Product Offerings

20.1.4 Key Strategies

20.1.5 Key Strengths

20.1.6 Key Opportunities

20.2 Boston Scientific

20.2.1 Business Overview

20.2.2 Boston Scientific in Global Coronary Stents Market

20.2.3 Major Product Offerings

20.2.4 Key Strategies

20.2.5 Key Strengths

20.2.6 Key Opportunities

20.3 Medtronic

20.3.1 Business Overview

20.3.2 Medtronic in Global Coronary Stent Market

20.3.3 Major Product Offerings

20.3.4 Key Strategies

20.3.5 Key Strengths

20.3.6 Key Opportunities

20.4 Biotronik

20.4.1 Business Overview

20.4.2 BIOTRONIK in Global Coronary Stents Market

20.4.3 Major Product Offerings

20.4.4 Key Strategies

20.4.5 Key Strengths

20.4.6 Key Opportunities

20.5 Terumo

20.5.1 Business Overview

20.5.2 Terumo in Global Coronary Stents Market

20.5.3 Product Offerings

20.5.4 Key Strategies

20.5.5 Key Strengths

20.5.6 Key Opportunities

20.6 B. Braun Melsungen

20.6.1 Business Overview

20.6.2 B. Braun Melsungen in Global Coronary Stents Market

20.6.3 Major Product Offerings

20.6.4 Key Strategies

20.6.5 Key Strengths

20.6.6 Key Opportunities

20.7 Biosensors International Group

20.7.1 Business Overview

20.7.2 Biosensors International Group in Global Coronary Stents Market

20.7.3 Major Product Offerings

20.7.4 Key Strategies

20.7.5 Key Strengths

20.7.6 Key Opportunities

21 Other Prominent Vendors

21.1 Arterial Remodeling Technologies

21.1.1 Business Overview

21.1.2 Major Product Offerings

21.2 Alvimedica

21.2.1 Business Overview

21.2.2 Major Product Offerings

21.3 Balton

21.3.1 Business Overview

21.3.2 Major Product Offerings

21.5 Cardionovum

21.5.1 Business Overview

21.5.2 Major Product Offerings

21.6 CeloNovaBioSciences

21.6.1 Business Overview

21.6.2 Major Product Offerings

21.7 Comed

21.7.1 Business Overview

21.7.2 Major Product Offerings

21.8 Cordis

21.8.1 Business Overview

21.8.2 Major Product Offerings

21.9 Elixir Medical

21.9.1 Business Overview

21.9.2 Major Product Offerings

21.10 ENDOCOR

21.10.1 Business Overview

21.10.2 Major Product Offerings

21.11 Eucatech

21.11.1Business Overview

21.11.2Major Product Offerings

21.12 Eurocor Tech

21.12.1Business Overview

21.12.2Major Product Offerings

21.13 HEXACATH

21.13.1Business Overview

21.13.2Major Product Offerings

21.14 InSitu Technologies

21.14.1Business Overview

21.14.2Major Product Offerings

21.15 Innovative Health Technologies

21.15.1Business Overview

21.15.2Major Product Offerings

21.16 Lepu Medical Technology (Beijing)

21.16.1Business Overview

21.16.2Major Product Offerings

21.17 Medinol

21.17.1Business Overview

21.17.2Major Product Offerings

21.18 Meril Life Sciences

21.18.1Business Overview

21.18.2Major Product Offerings

21.19 Micell Technologies

21.19.1Business Overview

21.19.2Major Product Offerings

21.20 MicroPort Scientific

21.20.1 Business Overview

21.20.2Major Product Offerings

21.21 Minvasys

21.21.1Business Overview

21.21.2 Major Product Offerings

21.22 ORBUSNEICH MEDICAL

21.22.1Business Overview

21.22.2Major Product Offerings

21.23 Q3 Medical Devices

21.23.1Business Overview

21.23.2Major Product Offerings

21.24 REVA Medical

21.24.1Business Overview

21.24.2Major Product Offerings

21.25 Rontis

21.25.1Business Overview

21.25.2Major Product Offerings

21.26 S3V Vascular Technologies

21.26.1Business Overview

21.26.2Major Product Offerings

21.27 Sahajanand Medical Technologies

21.27.1Business Overview

21.27.2Major Product Offerings

21.28 SCITECH

21.28.1Business Overview

21.28.2Major Product Offerings

21.29 STENTYS

21.29.1Business Overview

21.29.2Major Product Offerings

21.30 Svelte Medical

21.30.1 Business Overview

21.30.2Major Product Offerings

21.31 Translumina Therapeutics

21.31.1Business Overview

21.31.2Major Product Offerings

21.32 USM HEALTHCARE

21.32.1Business Overview

21.32.2Major Product Offerings

21.33 Vascular Concepts

21.33.1Business Overview

21.33.2Major Product Offerings

21.34 Wellinq

21.34.1Business Overview

21.34.2Major Product Offerings

22 Report Summary

22.1 Key Takeaways

22.2 Strategic Recommendations

22.3 Quantitative Summary

22.3.1 Product Type

22.3.2 Design Type

22.3.3 End-Users

22.3.4 Geography

23 Appendix

23.1 Abbreviations

List of Exhibits       

Exhibit 1         Segmentation of Global Coronary Stent Market

Exhibit 2         Market Size Calculation Approach 2018

Exhibit 3         Evolution of Coronary Stents for Treating CAD

Exhibit 4         Different Types of Coronary Stents Available in the Market

Exhibit 5         Impact of Increased Prevalence/Incidence of Coronary Artery Disease

Exhibit 6         Impact of High Demand for DESs with Low Strut Thickness

Exhibit 7         Impact of High Demand for Coronary Stents in Emerging Markets

Exhibit 8         Incremental Growth of Coronary Stents Market in India

Exhibit 9         Incremental Growth of Coronary Stents Market in China

Exhibit 10       Impact of Technological Advancements/Innovations in Stent Platforms

Exhibit 11       Impact of Stringent Regulations for Product Approvals

Exhibit 12       Impact of Availability of Alternative Treatment Methods for CAD

Exhibit 13       Impact of Complications Associated with Coronary Stenting Procedure

Exhibit 14       Impact of Emergence of Bioresorbable Vascular Scaffolds

Exhibit 15       Impact of High Growth Potential of Third-generation DESs

Exhibit 16       Impact of New Product Approvals/Launches

Exhibit 17       Market by Product Type 2018 (%)

Exhibit 18       Market By Geography 2018 & 2024 (%)

Exhibit 19       Key Countries

Exhibit 20       Market By Region: Incremental Growth

Exhibit 21       Global Coronary Stent Market 2018−2024 ($ million)

Exhibit 22       Five Forces Analysis 2018

Exhibit 23       Incremental Growth by Product 2018−2024

Exhibit 24       Market by Product Type

Exhibit 25       Market by Product Type 2018 & 2024 (%)

Exhibit 26       Market by Product Type 2018−2024 ($ million)

Exhibit 27       Market by Product Type 2018−2024 (%)

Exhibit 28       Market by Product Type: Absolute Growth

Exhibit 29       Global Drug-eluting Coronary Stent Market 2018−2024 ($ million)

Exhibit 30       Global Drug-eluting Stents Market by Product Type

Exhibit 31       Global Drug-eluting Stents Market by Product Type 2018 & 2024 (%)

Exhibit 32       Global Drug-eluting Stents Market by Product Type 2018−2024 ($ million)

Exhibit 33       Global Drug-eluting Stents Market by Product Type 2018−2024 (%)

Exhibit 34       Global Second-generation Drug-eluting Stents Market 2018−2024 ($ million)

Exhibit 35       Global Latest-generation Drug-eluting Stents Market 2018−2024 ($ million)

Exhibit 36       Global Bare Metal Coronary Stent Market 2018−2024 ($ million)

Exhibit 37       Global Bioresorbable Coronary Stent Market 2018−2024 ($ million)

Exhibit 38       Incremental Growth by Design 2018−2024

Exhibit 39       Market by Design Type

Exhibit 40       Market by Design Type 2018 & 2024 (%)

Exhibit 41       Market by Design Type 2018−2024 ($ million)

Exhibit 42       Market by Design Type 2018−2024 (%)

Exhibit 43       Market by Design Type: Absolute Growth

Exhibit 44       Global Permanent Coronary Stent Market by Product 2018 (%)

Exhibit 45       Global Permanent Coronary Stent Market 2018−2024 ($ million)

Exhibit 46       Global Fully Degradable Coronary Stent Market 2018−2024 ($ million)

Exhibit 47       Incremental Growth by End-users 2018−2024

Exhibit 48       Market by End-user Type

Exhibit 49       Market by End-users: Absolute Growth

Exhibit 50       Market by End-user Type 2018 & 2024 (%)

Exhibit 51       Market by End-user Type 2018−2024 ($ million)

Exhibit 52       Market by End-user Type 2018−2024 (%)

Exhibit 53       Global Coronary Stents Hospitals Market 2018–2024 ($ million)

Exhibit 54       Market by SCCs 2018–2024 ($ million)

Exhibit 55       Market by ASCs 2018–2024 ($ million)

Exhibit 56       Incremental Growth by Geography 2018−2024

Exhibit 57       Market by Geography

Exhibit 58       Market by Region: Market Share & CAGR

Exhibit 59       Market by Region: Absolute Growth

Exhibit 60       Market by Geography 2018 & 2024 (%)

Exhibit 61       Market by Geography 2018 & 2024 (%)

Exhibit 62       Market by Geography 2018 & 2024 (%)

Exhibit 63       Market in North America by Country 2018 (%)

Exhibit 64       Market in North America 2018–2024 ($)

Exhibit 65       Incremental Growth in North America 2018−2024

Exhibit 66       Market in US 2018–2024 ($ million)

Exhibit 67       Market in Canada 2018−2024 ($ million)

Exhibit 68       Market in Europe: Key Countries

Exhibit 69       Market in Europe 2018−2024 ($ million)

Exhibit 70       Incremental Growth in Europe 2018−2024

Exhibit 71       Market in Germany 2018−2024 ($ million)

Exhibit 72       Market in France 2018−2024 ($ million)

Exhibit 73       Market in UK 2018−2024 ($ million)

Exhibit 74       Incremental Growth Comparison Across Regions During Forecast Period ($ Mn)

Exhibit 75       Market in APAC: Key Countries

Exhibit 76       Market in APAC 2018−2024 ($ million)

Exhibit 77       Incremental Growth in APAC 2018−2024

Exhibit 78       Market in Japan 2018−2024 ($ million)

Exhibit 79       Market in China 2018−2024 ($ million)

Exhibit 80       Major Factors Driving Coronary Stents Market in India

Exhibit 81       Coronary Stents Market in India 2018−2024 ($ million)

Exhibit 82       Market in Latin America: Key Countries

Exhibit 83       Coronary Stents Market in Latin America 2018−2024 ($ million)

Exhibit 84       Incremental Growth in Latin America 2018−2024

Exhibit 85       Coronary Stents Market in Brazil 2018−2024 ($ million)

Exhibit 86       Coronary Stents Market in Mexico 2018−2024 ($ million)

Exhibit 87       Market in MEA: Key Countries

Exhibit 88       Coronary Stents Market in MEA 2018−2024 ($ million)

Exhibit 89       Incremental Growth in MEA 2018−2024

Exhibit 90       Coronary Stents Market in Turkey 2018−2024 ($ million)

Exhibit 91       Market in Saudi Arabia 2018−2024 ($ million)

Exhibit 92       Market: Vendors Market Share 2018 (%)

Exhibit 93       Market: Top Vendors Market Shares 2018 (%)

Exhibit 94       Abbott: R&D Spend in FY2016, FY2017 and FY2018 ($ million)

Exhibit 95       Abbott: Sales Breakdown by Segments in FY2017 and FY2018 ($ million)

Exhibit 96       Abbott Sales Breakdown by Geography 2018 (%)

Exhibit 97       Boston Scientific: R&D Expenditure in FY16, FY17 and FY18 ($ million)

Exhibit 98       Boston Scientific: Revenue Breakdown by Product Category 2017 and 2018 ($ million)

Exhibit 99       Boston Scientific: Revenue Share by Geography 2018 (%)

Exhibit 100     Medtronic Sales Breakdown by Segments FY2018 (%)

Exhibit 101     Medtronic R&D Expenditure FY16-FY18 ($ million)

Exhibit 102     Medtronic Revenue Breakdown by Geography FY2018 (%)

Exhibit 103     Medtronic Revenue by Business Segments in FY17 and FY18 ($ million)

Exhibit 104     Terumo: Research & Development Spend in FY15, FY16, and FY17 ($ million)

Exhibit 105     Terumo: Sales by Business Segment in FY2017 (%)

Exhibit 106     Terumo: Cardiovascular Revenue by Geography FY2017 (%)

Exhibit 107     B. Braun Melsungen R&D Expenditure in FY16, FY17, and FY18 ($ million)

Exhibit 108     B. Braun Melsungen Revenue by Division FY2017 and FY2018 ($ million)

Exhibit 109     B. Braun Melsungen Sales by Region FY18 (%)

           

List of Tables          

Table 1            Key Caveats

Table 2            Currency Conversion 2013−2018

Table 3            Historical Milestones in Coronary Artery Stenting

Table 4            Popular DESs with Low Strut Thickness

Table 5            Absolute Growth of Coronary Stents in Developed and Emerging Economies (%)

Table 6            List of Major Advanced and Innovative Coronary Stents

Table 7            Commercially Available Bioresorbable Coronary Stents

Table 8            Investigational Bioresorbable Coronary Stents

Table 9            List of Popular Biodegradable Polymer Coating Drug-eluting Stents

Table 10         Recent Product Approvals in Global Coronary Stent Market

Table 11         List of Popular DESs from Prominent Players

Table 12         List of Popular BMSs from Prominent Players

Table 13         Commercially Available Bioresorbable Stents

Table 14         Investigational Bioresorbable Stents

Table 15         Market: Vendors Ranking 2018

Table 16         Abbott: Product Offerings

Table 17         Boston Scientific: Key Product Approval Milestone

Table 18         Boston Scientific: Product Offerings

Table 19         Medtronic: Product Offerings

Table 20         BIOTRONIK: Product Offerings

Table 21         Terumo: Product Offerings

Table 22         B. Braun Melsungen’s Therapy Fields & Applications

Table 23         B. Braun Melsungen: Product Offerings

Table 24         Biosensors International Group: Product Offerings

Table 25         Market by Product Type ($ million)

Table 26         Market by Product Type (%)

Table 27         Market by Design ($ million)

Table 28         Market by Design (%)

Table 29         Market by End-users ($ million)

Table 30         Market by End-users (%)

Table 31         Market by Geography ($ million)

Table 32         Market by Geography (%)

Select a license type that suits your business needs

single-user Single User Licence
$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4000.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5000.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date